April 15, 2010
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Crystalens AO granted NTIOL status
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
ALISO VIEJO, Calif. — The Centers for Medicare and Medicaid Services has granted New Technology Intraocular Lens status for Bausch + Lomb's Crystalens AO, the company announced in a press release.
Effective April 9, the classification will allow Medicare to reimburse ASCs an additional $50 for cataract procedures when the Crystalens AO is implanted, the release said.
The Crystalens AO, which was approved by the U.S. Food and Drug Administration last year, is the first presbyopia-correcting IOL to receive NTIOL classification.
Follow OSNSuperSite.com
on Twitter.